FeesSafety
Pluang+

Royale Energy starts trading on OTCQB after regaining SEC compliance, boosting market access.

Market News
04 Nov 2026, 16:00 WIB
GlobeNewsWire
View Source
Bullish
Royale Energy starts trading on OTCQB after regaining SEC compliance, boosting market access.

Royale Energy, an oil and gas company, began trading its common stock on the OTCQB Venture Market on November 4, 2026, following the restoration of its SEC reporting compliance. This move marks a key milestone in improving transparency and access to investors, enhancing the company's capital markets position. Royale aims to strengthen its financial foundation and explore future listing opportunities on national exchanges as part of its growth strategy.

Royale Energy's commencement of trading on the OTCQB Venture Market is noted alongside Pluang's snapshot of the Energy sector as of Nov 04, 2026 20:31 WIB. Of 79 priced Energy-sector US stocks on Pluang, 27 rose and 50 fell today. Among notable movers, Baker Hughes Co (BKR) rose 2.10% to USD 53.90 with a typical hold time of 76 days, while Equinor ASA (EQNR) fell 2.34% to USD 44.56 with 100% buy order activity.

More News

Good Life Meds must stop unproven health and personalization claims for compounded Tirzepatide+ products.

Good Life Meds must stop unproven health and personalization claims for compounded Tirzepatide+ products.

The National Advertising Division (NAD) recommended that Good Life Meds discontinue claims about health benefits and personalization for its compounded Tirzepatide+ weight loss products after a challenge by Eli Lilly. NAD found that Good Life lacked ...

Market News
Bearish
26 minutes ago
Moleculin's Annamycin shows promising remission rates in AML trial, data to be presented at ASH 2026.

Moleculin's Annamycin shows promising remission rates in AML trial, data to be presented at ASH 2026.

Moleculin Biotech announced that interim results from its Phase 2/3 trial of Annamycin for relapsed or refractory acute myeloid leukemia (AML) will be presented at the 2026 ASH Annual Meeting. The trial showed remission rates of 43% and 36% in two An...

Company Fundamentals
Bullish
26 minutes ago
ANZ dental implants market to grow 5% CAGR, reaching $393M by 2033 driven by aging population and prosthetic demand

ANZ dental implants market to grow 5% CAGR, reaching $393M by 2033 driven by aging population and prosthetic demand

The Australia and New Zealand (ANZ) dental implants market, valued at $266 million in 2025, is projected to grow at a 5% CAGR to $393 million by 2033. Growth is driven by increasing demand for oral rehabilitation and prosthetic dentistry, especially ...

Market News
Bullish
26 minutes ago
New study shows Asgard's tech induces cancer-fighting structures in tumors, boosting therapy success across 7 cancer types.

New study shows Asgard's tech induces cancer-fighting structures in tumors, boosting therapy success across 7 cancer types.

Asgard Therapeutics published a study in Immunity demonstrating its technology can reprogram tumor cells into dendritic cells, inducing cancer-fighting tertiary lymphoid structures (imgTLSs) across seven tumor types. This tumor-agnostic approach led ...

Others
Bullish
26 minutes ago
Cap expands onchain credit marketplace to finance film production without tokenizing assets

Cap expands onchain credit marketplace to finance film production without tokenizing assets

Cap, an onchain credit marketplace, is expanding into film and media financing by providing funding for the upcoming film Wake. This deal uses advances against anticipated film production tax credits, showing how Cap's underwriting model supports spe...

Market News
Bullish
26 minutes ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App